Trial Details
RECRUITINGBasic Information
| Clinical ID | c42 |
|---|---|
| Identifier | NCT07303686 |
| Trial Title | De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease (CD)|Ulcerative Colitis (UC) |
| Interventions | BIOLOGICAL: Ustekinumab 90 mg SC q8w|BIOLOGICAL: Ustekinumab 90 mg SC q12w |
Participant Information
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre |
|---|---|
| City | Quebec |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-10-08 |
|---|---|
| Primary Completion Date | 2027-04-15 |
| Completion Date | 2027-10-15 |